跳转至内容
Merck
CN
所有图片(1)

主要文件

安全信息

EHU129531

Sigma-Aldrich

MISSION® esiRNA

targeting human TMSB15A

登录查看公司和协议定价


About This Item

UNSPSC代码:
41105324
NACRES:
NA.51

描述

Powered by Eupheria Biotech

质量水平

产品线

MISSION®

表单

lyophilized powder

esiRNA cDNA靶序列

AGCCAGACTTGTCGGAAGTGGAGAAGTTTGACAGGTCAAAACTGAAGAAAACTAATACTGAAGAAAAAAATACTCTTCCCTCAAAGGAAACTATCCAGCAAGAGAAAGAGTGTGTTCAAACATCATAAAATGGGGATCGCCTCCCAACAGCAGATTTCGACATTACCTGAGAGTCTTGATTTTAGGCTTGTTTTTTGTAAACCCATGTGTTTGTAGAGATTTTAGGCGTCTTCGGATATCTTCTCACCTATGTTCCCTGGCTAAGAAGTCAGAGGTAGCCAATGTTTCCTTAAATTCATTTTTAAACTTACCATTGGTGCATATGTTCCAGATGGCAGATGCTGTCAATAATCTCACCATTGATGACCTTTGTGTATGTAGTTCTTGCATCCTATACTGGATAAGCCTGTTTTAACCTGCTATGATGGGTGCTTCCAT

基因组数据库 |人类登记号

NCBI登记号

运输

ambient

储存温度

−20°C

基因信息

一般描述

MISSION esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

法律信息

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

10 - Combustible liquids

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

S Darb-Esfahani et al.
British journal of cancer, 107(11), 1892-1900 (2012-10-20)
Biomarkers predictive of pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) of breast cancer are urgently needed. Using a training/validation approach for detection of predictive biomarkers in HER2-negative breast cancer, pre-therapeutic core biopsies from four independent cohorts were investigated: Gene

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门